Retraction notices

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model”

Type
Expression of concern
Notice date
4/23/2020 0:00
Journal
International Journal of Nephrology and Renovascular Disease
Publisher
Taylor and Francis - Dove Press
Notice DOI
10.2147/ijnrd.s240218
Original paper DOI
10.2147/ijnrd.s22783

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.